SI-BONE, Inc. Stock News

Delivered ~20 % U.S. procedure volume growth in the third quarter Third Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $55.7 million, representing growth of 14.5%   U.S. revenue of $52.8 million, representing growth of 13.9% Gross margin of 79.3%   Net loss of $3.6 million, representing an improvement of 20.7%   Positive adjusted EBITDA of ...

FDA Breakthrough Device Designated (BDD) platform engineered for durable fixation in low density bone FDA Breakthrough Device Designated (BDD) platform engineered for durable fixation in low density bone

Delivered ~15% WW revenue growth and ~ 178% increase in adjusted EBITDA ~ 19% increase in U.S. physician base

Ian Wells, former Global Chief Financial Officer of HOYA Vision Care, appointed CFO, bringing multi-billion-dollar P&L leadership and capital-markets discipline Tom West, who led Intersect ENT to its $1.1 billion acquisition by Medtronic and Nalu Medical to its $600 million acquisition by Boston Scientific, joins as an Independent Board Member Appointments build the financial and governance fou...

Gazprom Neft , ​the oil arm ‌of Russia's energy giant ​Gazprom , ​said on Friday its ⁠first-quarter ​net profit declined ​by 3.5% year-on-year to 95.8 ​billion roubles ($1.35 ​billion).

SiBone NASDAQ: SIBN raised its full-year 2026 outlook after reporting double-digit revenue growth in the first quarter, with management pointing to new product launches, expanding physician adoption, international momentum and a proposed Medicare reimbursement change as key drivers for the year ahead.